Hyperandrogenaemia, polycystic ovary syndrome, and physical fitness in women-a Northern Finland birth cohort study
- PMID: 40238990
- DOI: 10.1093/ejendo/lvaf080
Hyperandrogenaemia, polycystic ovary syndrome, and physical fitness in women-a Northern Finland birth cohort study
Abstract
Objective: To investigate the independent associations of hyperandrogenaemia (HA) and polycystic ovary syndrome (PCOS) with physical fitness in women among the general population.
Design: A population-based birth cohort study including 5889 women.
Methods: Longitudinal associations of serum testosterone (T), free androgen index (FAI), and PCOS with cardiorespiratory fitness (CRF) (measured by heart rate after a submaximal exercise test) and grip strength over the 31 to 46 years of age timespan were examined using multivariable linear mixed models adjusted for time, body mass index, homeostatic model assessment of insulin resistance, physical activity and smoking. The results are reported as regression coefficients (β) with corresponding 95% confidence intervals [95% CI].
Results: The third and fourth T and FAI quartiles were associated positively with higher heart rate after the submaximal exercise test in multivariable models indicating poorer CRF compared with women in Q1 of T and FAI (Q3: β of T = 1.58 [95% CI: 0.21 to 2.96], β of FAI = 1.97 [0.54 to 3.39]; Q4: β of T = 1.88 [0.46 to 3.30], β of FAI = 2.70 [1.15 to 4.25]). The second, third, and fourth quartiles of FAI were associated with higher grip strength in multivariable models compared with women in Q1 (Q2: β = 0.59 [0.04 to 1.14], Q3: β = 0.74 [0.16 to 1.30], Q4: β = 0.68 [0.06 to 1.27]). Excluding women with PCOS did not alter these results, while PCOS itself was not associated with CRF or grip strength.
Conclusion: Hyperandrogenaemia in premenopausal women was associated with poorer CRF but better grip strength, independently of PCOS, which suggests that HA, rather than PCOS, has an independent and complex association with physical fitness in premenopausal women.
Keywords: PCOS; hyperandrogenaemia; physical fitness; physical performance; testosterone.
© The Author(s) 2025. Published by Oxford University Press on behalf of European Society of Endocrinology.
Conflict of interest statement
Conflict of interest: T.T.P. is on the editorial board of European Journal of Endocrinology. She was not involved in the review or editorial process for this paper, on which she is listed as an author. T.T.P declares consulting fees from Gedeon Richter, Organon, Astellas, Roche; speaker's fees from Gedeon Richter, Exeltis, Roche, Stragen, Merck, Organon; travel support from Gedeon Richter. The other authors do not have any conflicts of interest to declare.
MeSH terms
Substances
Grants and funding
- Ida Montin Foundation
- Emil Aaltonen Foundation
- Finnish Medical Foundation
- Jenny and Antti Wihuri Foundation
- Sigrid Juselius Foundation
- 315921/2018/Research Council of Finland
- OKM/54/626/2019/Ministry of Education and Culture of Finland
- Roche Diagnostics International Ltd
- Novo Nordisk
- Medical Research Center
- 65354/University of Oulu
- 2/97/Oulu University Hospital
- 23/251/97/Ministry of Health and Social Affairs
- 54121/National Institute for Health and Welfare, Helsinki
- 50621/Regional Institute of Occupational Health, Oulu, Finland
- 539/2010 A31592/ERDF European Regional Development Fund
